ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 31, 2004

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

Prevention Task Force Unable To Reach Consensus On New Division, Tries To Avoid More Disruption

July 6, 1979

Summit Conference Reviews Leads In Leukemia, Lymphoma

January 8, 1982

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988